Related Experiment Videos
Summary
Cherry-red spot-myoclonus syndrome (CRSM) is a rare genetic disorder. This case study highlights typical clinical and biochemical findings, including reduced neuraminidase activity, in a young woman with CRSM.
Area of Science:
- Ophthalmology
- Genetics
- Neurology
Background:
- Cherry-red spot-myoclonus syndrome (CRSM) is a rare inherited lysosomal storage disorder.
- It is characterized by progressive myoclonus epilepsy, ataxia, and visual impairment.
Observation:
- A 21-year-old woman presented with typical CRSM symptoms, including reduced visual acuity (20/50), ocular oscillations, nystagmus, and cherry-red maculas.
- Neurological examination revealed optic atrophy, and visual evoked potentials were significantly diminished, while electroretinography remained normal.
Findings:
- Biochemical analysis showed significantly reduced neuraminidase enzyme activity in cultured fibroblasts from the patient and her parents.
- Lysosomal inclusions, likely containing oligosaccharides, were identified in the patient's conjunctival fibroblasts, confirming the diagnosis.
Implications:
- This case reinforces the characteristic clinical and biochemical profile of CRSM.
- Early diagnosis through enzyme assays and genetic testing is crucial for potential management strategies.
- Understanding the pathophysiology aids in developing targeted therapies for this rare neurological disorder.